The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Material properties in complement activation
Open accessAbstract
Uncontrolled complement activation can induce many inflammatory and life threatening conditions. Accordingly, the role of complement in initiation of adverse reactions to polymers and nanoparticulate drug carriers is receiving increasing attention and has prompted extensive 'structure-immune performance' relationship studies in nanomedicine research at many fronts. The interaction between nanomaterials and the complement system is complex and regulated by inter-related factors that include nanoscale size, morphology and surface characteristics. Each of these parameters may affect complement activation differently and through different sensing molecules and initiation pathways. The importance of material properties in triggering complement is considered and mechanistic aspects discussed. Mechanistic understanding of complement events could provide rational approaches for improved material design and nanoengineering strategies for clinical medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Self-citationWalport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Self-citationMonopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441506 · Cited by 1,481
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Self-citationModulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 778
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700465 · Cited by 777
Complement evasion by human pathogens
Lambris, J. D., Ricklin, D., & Geisbrecht, B. V. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1824 · Cited by 722
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie · doi:10.1002/ange.200700465 · Cited by 655
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
Szebeni, J. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.023 · Cited by 611
Regulation of B Lymphocyte Responses to Foreign and Self-Antigens by the CD19/CD21 Complex
Fearon, D. T., Carroll, M. C., & Carroll, M. C. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.393 · Cited by 532
Complement-targeted therapeutics
Ricklin, D., & Lambris, J. D. (2007) · Nature Biotechnology · doi:10.1038/nbt1342 · Cited by 481
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
Management and Preparedness for Infusion and Hypersensitivity Reactions
Lenz, H.-J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-5-601 · Cited by 479
Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., & Gabizon, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1777 · Cited by 477
Hattori, R., Hamilton, K. K., McEver, R. P., & Sims, P. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81901-9 · Cited by 438
Complement activation and protein adsorption by carbon nanotubes
SALVADORMORALES, C., FLAHAUT, E., SIM, E., SLOAN, J., HGREEN, M., & SIM, R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.02.006 · Cited by 434
Wang, X., Ishida, T., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.010 · Cited by 421
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382
Regulation of Toll-like receptor–mediated inflammatory response by complement in vivo
Zhang, X., Kimura, Y., Fang, C., Zhou, L., Sfyroera, G., Lambris, J. D., Wetsel, R. A., Miwa, T., & Song, W.-C. (2007) · Blood · doi:10.1182/blood-2006-12-063636 · Cited by 373
Structure of C3b reveals conformational changes that underlie complement activity
Janssen, B. J. C., Christodoulidou, A., McCarthy, A., Lambris, J. D., & Gros, P. (2006) · Nature · doi:10.1038/nature05172 · Cited by 369
Chonn, A., Cullis, P. R., & Devine, D. V. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.12.4234 · Cited by 367
Dos Santos, N., Allen, C., Doppen, A.-M., Anantha, M., Cox, K. A. K., Gallagher, R. C., Karlsson, G., Edwards, K., Kenner, G., Samuels, L., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.12.013 · Cited by 341
Szebeni, J., Alving, C. R., & Muggia, F. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.4.300 · Cited by 341
Mosqueira, V. C. F., Legrand, P., Gulik, A., Bourdon, O., Gref, R., Labarre, D., & Barratt, G. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00043-6 · Cited by 325
Hamad, I., Al-Hanbali, O., Hunter, A. C., Rutt, K. J., Andresen, T. L., & Moghimi, S. M. (2010) · ACS Nano · doi:10.1021/nn101990a · Cited by 276
Self-citationHamad, I., Hunter, A. C., Szebeni, J., & Moghimi, S. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.08.276 · Cited by 253
Self-citationBlunk, T., Hochstrasser, D. F., Sanchez, J., Müller, B. W., & Müller, R. H. (1993) · ELECTROPHORESIS · doi:10.1002/elps.11501401214 · Cited by 251
Salvador-Morales, C., Zhang, L., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.005 · Cited by 250
Peracchia, M. T., Harnisch, S., Pinto-Alphandary, H., Gulik, A., Dedieu, J. C., Desmaële, D., d’Angelo, J., Müller, R. H., & Couvreur, P. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00021-6 · Cited by 208
Rooijakkers, S. H. M., & van Strijp, J. A. G. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.011 · Cited by 207
Henry, S. P., Giclas, P. C., Leeds, J., Pangburn, M., Auletta, C., Levin, A. A., & Kornbrust, D. J. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36667-4 · Cited by 204
Moein Moghimi, S., Hamad, I., Andresen, T. L., Jørgensen, K., Szebeni, J., Moein Moghimi, S., Hamad, I., Andresen, T. L., Jørgensen, K., & Szebeni, J. (2006) · The FASEB Journal · doi:10.1096/fj.06-6186fje · Cited by 201
Self-citationSzebeni, J., Alving, C. R., Rosivall, L., Bünger, R., Baranyi, L., Bedöcs, P., Tóth, M., & Barenholz, Y. (2007) · Journal of Liposome Research · doi:10.1080/08982100701375118 · Cited by 199
Alberts, D. S., & Garcia, D. J. (1997) · Drugs · doi:10.2165/00003495-199700544-00007 · Cited by 182
Moghimi, S. M., Andersen, A. J., Hashemi, S. H., Lettiero, B., Ahmadvand, D., Hunter, A. C., Andresen, T. L., Hamad, I., & Szebeni, J. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.003 · Cited by 167
Self-citationMoghimi, S. M., & Hunter, A. C. (2001) · Pharmaceutical Research · doi:10.1023/a:1011054123304 · Cited by 161
Self-citationPrice, M., Cornelius, R. M., & Brash, J. L. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00330-3 · Cited by 152
Gbadamosi, J. K., Hunter, A. C., & Moghimi, S. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03710-9 · Cited by 150
Self-citationC3 Adsorbed to a Polymer Surface Can Form an Initiating Alternative Pathway Convertase
Andersson, J., Ekdahl, K. N., Larsson, R. L., Nilsson, U., & Nilsson, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5786 · Cited by 148
Szebeni, J. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i6.50 · Cited by 147
Szebeni, J., Alving, C. R., Sávay, S., Barenholz, Y., Priev, A., Danino, D., & Talmon, Y. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00006-6 · Cited by 147
Hamad, I. M., Hunter, A. C., Rutt, K. J., Liu, Z., Dai, H., & Moghimi, S. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.020 · Cited by 123
Self-citationMoghimi, S. M., Hunter, A. C., Dadswell, C., Sávay, S., Alving, C. R., & Szebeni, J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.02.005 · Cited by 120
Self-citationReview of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides
Srinivasan, S. K., & Iversen, P. L. (1995) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860090210 · Cited by 120
Szebeni, J., Baranyi, L., Sávay, S., Bodó, M., Milosevits, J., Alving, C. R., & Bünger, R. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00622.2005 · Cited by 113
The role of complement in Alzheimer’s disease pathology
Emmerling, M. R., Watson, M. D., Raby, C. A., & Spiegel, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00042-9 · Cited by 110
In Vivo Toxicological Effects of rel A Antisense Phosphorothioates in CD-1 Mice
Sarmiento, U. M., Perez, J. R., BECKER, J. M., & Narayanan, R. (1994) · Antisense Research and Development · doi:10.1089/ard.1994.4.99 · Cited by 109
Pedersen, M. B., Zhou, X., Larsen, E., Sørensen, U. B. S., Kjems, J., Nygaard, J. V., Nyengaard, J. R., Meyer, R. L., Boesen, T. P., & Vorup‐Jensen, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902214 · Cited by 106
Hamilton, K. K., Zhao, J., & Sims, P. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53740-6 · Cited by 102
Wu, Y., Qu, H., Sfyroera, G., Τζέκου, Α., Kay, B. K., Nilsson, B., Ekdahl, K. N., Ricklin, D., & Lambris, J. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003802 · Cited by 99
The Role of Complement Activation in Hypersensitivity to Pegylated Liposomal Doxorubicin (Doxil®)
Szebeni, J., Baranyi, L., Sávay, S., Lutz, H. U., Jelezarova, E., Bünger, R., & Alving, C. R. (2000) · Journal of Liposome Research · doi:10.3109/08982100009031112 · Cited by 93
Nontypeable Haemophilus influenzae Protein E Binds Vitronectin and Is Important for Serum Resistance
Hallström, T., Blom, A. M., Zipfel, P. F., & Riesbeck, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803226 · Cited by 91
Liposome-Mediated Triggering of Complement Cascade
Moghimi, S. M., & Hamad, I. M. (2008) · Journal of Liposome Research · doi:10.1080/08982100802309552 · Cited by 86
Self-citationMoghimi, S. M., Hamad, I. M., Bünger, R., Andresen, T. L., Jørgensen, K., Hunter, A. C., Baranji, L., Rosivall, L., & Szebeni, J. (2006) · Journal of Liposome Research · doi:10.1080/08982100600848801 · Cited by 80
Self-citationComplement activation on surfaces modified with ethylene glycol units
Arima, Y., Toda, M., & Iwata, H. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.10.015 · Cited by 78
Complement: Alive and Kicking Nanomedicines
Andersen, A. J., Hashemi, S. H., Andresen, T. L., Hunter, A. C., & Moghimi, S. M. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1045 · Cited by 70
Self-citationAl-Hanbali, O. A., Rutt, K. J., Sarker, D. K., Hunter, A. C., & Moghimi, S. M. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.406 · Cited by 69
Self-citationComplement activation on surfaces carrying amino groups
Toda, M., Kitazawa, T., Hirata, I., Hirano, Y., & Iwata, H. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.10.005 · Cited by 65
Polyethylene Glycol (PEG)-induced Mouse Model of Choroidal Neovascularization
Lyzogubov, V. V., Tytarenko, R. G., Liu, J., Bora, N. S., & Bora, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204701 · Cited by 64
Bradley, A. J., Brooks, D. E., Norris-Jones, R., & Devine, D. V. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00013-9 · Cited by 62
Sou, K., & Tsuchida, E. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.01.006 · Cited by 57
Engberg, A. E., Rosengren-Holmberg, J. P., Chen, H., Nilsson, B., Lambris, J. D., Nicholls, I. A., & Ekdahl, K. N. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33030 · Cited by 57
Salvador-Morales, C., Basiuk, E. V., Basiuk, V. A., Green, M. L. H., & Sim, R. B. (2008) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2008.090 · Cited by 57
Mangsbo, S. M., Sanchez, J., Anger, K., Lambris, J. D., Ekdahl, K. N., Loskog, A. S., Nilsson, B., & Tötterman, T. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902374 · Cited by 42
Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface
Nilsson, U., Storm, K., Elwing, H. B., & Nilsson, B. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90050-l · Cited by 41
Andersson, J., Bexborn, F., Klinth, J. E., Nilsson, B., & Ekdahl, K. N. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30377 · Cited by 38
Lutz, H. U., Fumia, S., Schurtenberger, C., & Alaia, V. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.146 · Cited by 23
Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines
Moghimi, S. M., & Andresen, T. L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.014 · Cited by 20
Self-citation
Cited by
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.061 · Cited by 1,004
Magnetic Soft Materials and Robots
Kim, Y., & Zhao, X. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00481 · Cited by 873
Safety of Nanoparticles in Medicine
Wolfram, J., Zhu, M., Yang, Y., Shen, J., Gentile, E., Paolino, D., Fresta, M., Nie, G., Chen, C., Shen, H., et al. (2015) · Current Drug Targets · doi:10.2174/1389450115666140804124808 · Cited by 532
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Soetaert, F., Korangath, P., Serantes, D., Fiering, S., & Ivkov, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.025 · Cited by 406
Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
Salmaso, S., & Caliceti, P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/374252 · Cited by 340
Metadata
- Authors
- Moghimi, S. M., Andersen, A. J., Ahmadvand, D., Wibroe, P. P., Andresen, T. L., & Hunter, A. C.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 63
- Issue
- 12
- Pages
- 1000-1007
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2066793829
- Cited by
- 268
- References
- 73
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.